Cardinal Health CAH Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Cost of product sold | $12.79B+1.9% | $12.8B+2.4% | $12.7B+1.8% | $12.64B+2.1% | $12.55B+1.6% | |
| Other Segments | $6.68B+35.1% | $6.28B+30.9% | $5.84B+25.6% | $5.38B+19.3% | $4.95B+14.4% | |
| Pharmaceutical and Specialty Solutions | $231.36B+12.9% | $225.68B+10.1% | $215.86B+4.1% | $204.64B-2.6% | $204.88B+0.5% | |
| Total Assets by Business | ||||||
| Cost of product sold | $27.9B-1.9% | $28.22B-1.4% | $28.28B— | $28.29B— | $28.45B— | |
| Other Segments | $16.23B+52.2% | $14.89B+40.1% | $13.54B— | $12.1B— | $10.66B— | |
| Pharmaceutical and Specialty Solutions | $160.43B+27.1% | $155.14B+28.2% | $143.86B— | $134.39B— | $126.22B— | |
| Total operating earnings by Business | ||||||
| Cost of product sold | $178M+58.9% | $192M+102% | $173M+96.6% | $135M+46.7% | $112M— | |
| Other Segments | $684M+46.5% | $639M+44.2% | $578M+34.1% | $516M+22.0% | $467M+15.9% | |
| Pharmaceutical and Specialty Solutions | $2.67B+21.2% | $2.55B+20.0% | $2.4B+14.6% | $2.26B+12.1% | $2.21B+9.2% | |
| Costs and Expenses by Business | ||||||
| Cost of product sold | $12.61B+1.3% | $12.61B+1.7% | $12.52B+1.6% | $12.5B+1.7% | $12.44B+1.1% | |
| Other Segments | $6B+35.1% | $5.64B+31.4% | $5.26B+26.8% | $4.87B+19.0% | $4.44B+11.7% | |
| Pharmaceutical and Specialty Solutions | $228.68B+14.6% | $223.13B+10.6% | $213.46B+4.9% | $202.39B-2.7% | $199.55B-1.6% | |
| Cost of products sold by Business | ||||||
| Cost of product sold | $10.57B+1.3% | $10.6B+2.3% | $10.5B+1.9% | $10.47B+2.0% | $10.43B+1.3% | |
| Other Segments | $4.98B+35.6% | $4.68B+32.4% | $4.36B+27.9% | $4.02B+19.5% | $3.67B+12.1% | |
| Pharmaceutical and Specialty Solutions | $225.87B+14.5% | $220.44B+10.4% | $210.95B+4.8% | $200B-2.8% | $197.29B-1.6% | |
| Segment Reporting, Long-Lived Asset, Expenditure for Addition by Business | ||||||
| Cost of product sold | $135M+27.4% | $131M+17.0% | $129M+3.2% | $133M-2.2% | $106M-29.2% | |
| Other Segments | $99M+37.0% | $92M+23.5% | $91M+25.1% | $88M+8.6% | $72.25M-2.0% | |
| Pharmaceutical and Specialty Solutions | $154M+105% | $150M+146% | $139M+104% | $118M+55.3% | $75M+5.6% | |
| D&A by Business | ||||||
| Cost of product sold | $211M-2.4% | $213M+0.7% | $218M+7.5% | $212M+3.4% | $216.25M+9.8% | |
| Other Segments | $85M-21.8% | $90M-7.7% | $100M+29.4% | $89M+12.7% | $108.75M+41.2% | |
| Pharmaceutical and Specialty Solutions | $263M+61.3% | $237M+43.6% | $219M+32.7% | $185M+0.5% | $163M-12.6% | |
| Goodwill by Business | ||||||
| Cost of product sold | $0— | $0— | $0— | $0— | $0— | |
| Other Segments | $6.99B+49.3% | $6.41B+37.0% | $5.83B+63.9% | $5.26B— | $4.68B— | |
| Pharmaceutical and Specialty Solutions | $35.44B+84.9% | $33.51B+123% | $27.96B— | $23.55B— | $19.16B— | |
| Distribution, selling, general and administrative expenses by Business | ||||||
| Cost of product sold | $2.05B+1.5% | $2.02B-1.0% | $2.03B-0.2% | $2.03B+0.3% | $2.02B0.0% | |
| Other Segments | $1.02B+32.7% | $957M+26.8% | $899M+21.6% | $843M+16.8% | $769.5M+9.9% | |
| Pharmaceutical and Specialty Solutions | $2.82B+24.7% | $2.69B+22.8% | $2.52B+16.7% | $2.39B+11.5% | $2.26B+5.8% | |
| Goodwill, Acquired During Period by Business | ||||||
| Cost of product sold | $0+100% | $0+100% | $0+100% | $0+100% | -$750K-150% | |
| Other Segments | $577M— | $578M— | $575M— | $578M— | $0— | |
| Revenue by Geography | ||||||
| Non-US | $1.71B+2.1% | $1.69B-0.8% | $1.68B-0.5% | $1.67B-0.7% | $1.68B— | |
| UNITED STATES | $249.12B+12.9% | $243.07B+10.2% | $232.71B+4.4% | $220.99B-1.9% | $220.7B-0.2% | |
| PP&E (Net) by Geography | ||||||
| Non-US | $1.74B— | —— | —— | —— | —— | |
| UNITED STATES | $9.76B— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cardinal Health break its business down?
- Cardinal Health (CAH) reports revenue by business across 3 parts — Cost of product sold, Other Segments and Pharmaceutical and Specialty Solutions. Each is extracted from the segment footnotes and tracked over time.
- Where does Cardinal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cardinal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
